David McAuliffe
Non Executive Director at Invex Therapeutics - Subiaco, Western Australia, Australia
David McAuliffe's Colleagues at Invex Therapeutics
David McAuliffe's Contact Details
HQ
Location
Perth,Western Australia,Australia
Perth,Western Australia,Australia
Company
Invex Therapeutics
Invex Therapeutics
David McAuliffe's Company Details
Invex Therapeutics (ASX: IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin™.
Frequently Asked Questions about David McAuliffe
David McAuliffe currently works for Invex Therapeutics.
David McAuliffe's role at Invex Therapeutics is Non Executive Director.
David McAuliffe's email address is ***@invextherapeutics.com. To view David McAuliffe's full email address, please signup to ConnectPlex.
David McAuliffe works in the Research industry.
David McAuliffe's colleagues at Invex Therapeutics are Narelle Warren and others.
David McAuliffe's phone number is